CBIS Latest News

Display # 
Cannabis Science (CBIS) Purchases Two Parcels of Cannabis Production Land from Apothecary Genetics, a Combined Total of 51 Acres; Licenses Land, Cultivation, and Formulation Usage in Major Growth Plan in California 24 Nov 2014
Cannabis Science Advances its Move into African Market from HIV to Cancer to the Ebola Virus With a Series of High-Level Meetings in Washington, D.C. 20 Nov 2014
Demand For Cannabis Science Drug Increases As Company Moves Into 2nd Stage Of Protocols For Pre-Clinical Drug Development, Thanks To Positive Laboratory Results From Its Operations In Spain 13 Nov 2014
Cannabis Science, Inc. (CBIS) is in the Final Stages to Acquire A British Columbia Company That Has Submitted "Marihuana For Medical Purposes" Application to Health Canada (As Previously Announced) 07 Nov 2014
Cannabis Science Announces Corporate Changes, Appointing Raymond Dabney As President And CEO And Dr. Dorothy Bray As Scientific Advisory Board Chair And Clinical Development Consultant 06 Nov 2014
Cannabis Science Enthused With CNN Monitoring The Outcome Of The National State By State Voting To Legalize Medical Cannabis 05 Nov 2014
Cannabis Science Releases Positive Laboratory Results From Both The EU Certified As Well As Its Own Unique Cannabis Strains Grown In Its Spain Operations 28 Oct 2014
Cannabis Science, Inc. (CBIS) Signs Drug Development and Laboratory Services Agreement with ImmunoClin Corporation (IMCL); Collaboration to Advance Clinical Studies and Formulations of the Company's Proprietary Cannabinoid Based Products 29 Sep 2014
Cannabis Science, Inc. (CBIS) And Unistraw Holdings Join Forces To Produce Proprietary Formulations Delivering A Wide Array Of Unique Cannabis Extracts And Pure Cannabinoid-Based Products 16 Sep 2014
Cannabis Science Provides Updated Guidance on its Current Pre-Clinical Drug Development Programs Beginning with the Scientific Cannabis Cultivation Programs in Europe and North America, Testing Multiple Cannabis Strains for Multiple Critical Ailments 26 Aug 2014